Prevalence and type distribution of human papillomavirus among 1813 men in Tanzania and the relationship to HIV status

Sexually Transmitted Diseases

Volumn 40, Issue 7, 2013, Pages 592-598

  Olesen, Tina Bech ^a   Iftner, Thomas ^b   Mwaiselage, Julius ^c   Kahesa, Crispin ^c   Rasch, Vibeke ^d   Ngoma, Twalib ^c   Munk, Christian ^a   Kjaer, Susanne Krüger ^a,e  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b Universitaetsklinikum ^*  (Germany)

^c Ocean Road Cancer Institute   (Tanzania)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; GENOTYPE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 66; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PREVALENCE; TANZANIA; WART VIRUS; ADOLESCENT; COMPLICATION; CONFIDENCE INTERVAL; DEMOGRAPHY; GENETICS; HIV INFECTIONS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PENILE DISEASES; SEXUALLY TRANSMITTED DISEASES, VIRAL; SPECIES DIFFERENCE; VIREMIA; VIROLOGY; YOUNG ADULT;

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE FACTORS; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; GENOTYPE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PENILE DISEASES; PREVALENCE; SEXUALLY TRANSMITTED DISEASES, VIRAL; SPECIES SPECIFICITY; TANZANIA; VIREMIA; YOUNG ADULT;

EID: 84888642595     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31828fcf57     Document Type: Article

References (32)

1. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 90: Human Papillomaviruses. Lyon, France: International Agency for Research on Cancer, 2007.
2. Giuliano AR, Lazcano-Ponce E, Villa LL, et al. The human papillomavirus infection in men study: Human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008; 17:2036-2043.
3. Dunne EF, Nielson CM, Stone KM, et al. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006; 194:1044-1057.
4. Smith JS, Gilbert PA, Melendy A, et al. Age-specific prevalence of human papillomavirus infection in males: A global review. J Adolesc Health 2011; 48:540-552.
5. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
6. Tobian AA, Kigozi G, Gravitt PE, et al. Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa. AIDS 2012; 26:1555-1565.
7. Joint United Nations Programme on HIV/AIDS (UNAIDS)YWHO. Revised recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1997; 72:81-87.
8. Veldhuijzen NJ, Dhont N, Vyankandondera J, et al. Prevalence and concordance of HPV, HIV, and HSV-2 in heterosexual couples in Kigali, Rwanda. Sex Transm Dis 2012; 39:128-135.
9. Muller EE, Chirwa TF, Lewis DA. Human papillomavirus (HPV) infection in heterosexual South African men attending sexual health services: Associations between HPVand HIV serostatus. Sex Transm Infect 2010; 86:175-180.
10. Ng'ayo MO, Bukusi E, Rowhani-Rahbar A, et al. Epidemiology of human papillomavirus infection among fishermen along Lake Victoria Shore in the Kisumu District, Kenya. Sex Transm Infect 2008; 84:62-66.
11. UNAIDSYUnited Republic of Tanzania. HIV and AIDS estimates (2011). [UNAIDS]. Available at: http://www.unaids.org/en/regionscountries/countries/ unitedrepublicoftanzania/Accessed January 28, 2013.
12. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet 2007; 370:890-907.
13. Tobian AA, Grabowski MK, Kigozi G, et al. High-risk human papillomavirus prevalence is associated with HIV infection among heterosexual men in Rakai, Uganda. Sex Transm Infect 2013; 89: 122-127.
14. Dartell M, Rasch V, Kahesa C, et al. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: The PROTECT study. Sex Transm Dis 2012; 39:201-208.
15. Bruni L, Diaz M, Castellsague X, et al. Cervical human papillomavirus prevalence in 5 continents:Meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010; 202:1789-1799.
16. Smith JS, Backes DM, Hudgens MG, et al. Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men. Int J Cancer 2010; 126:572-577.
17. Auvert B, Lissouba P, Cutler E, et al. Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J Acquir Immune Defic Syndr 2010; 53:111-116.
18. Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005; 337:76-84.
19. Miralles-Guri C, Bruni L, Cubilla AL, et al. Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol 2009; 62:870-878.
20. Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111:278-285.
21. Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475.
22. Moscicki AB, Ellenberg JH, Farhat S, et al. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: Risk factors and differences, by phylogenetic type. J Infect Dis 2004; 190:37-45.
23. Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003; 31:14-19.
24. Kjaer SK, Munk C, Winther JF, et al. Acquisition and persistence of human papillomavirus infection in younger men: A prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 2005; 14:1528-1533.
25. Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423-428.
26. Mbulawa ZZ, Coetzee D, Marais DJ, et al. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis 2009; 199:1514-1524.
27. van der Loeff MF, Nyitray AG, Giuliano AR. HPV vaccination to prevent HIV infection: Time for randomized controlled trials. Sex Transm Dis 2011; 38:640-643.
28. Tobian AA, Grabowski MK, Kigozi G, et al. Human papillomavirus clearance in men is associated with HIV acquisition and increased foreskin dendritic cell density in Rakai, Uganda. J Infect Dis 2013. [Epub ahead of print].
29. Kjaer SK, van den Brule AJ, Paull G, et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: Population based prospective follow up study. BMJ 2002; 325:572.
30. Koshiol J, Lindsay L, Pimenta JM, et al. Persistent human papillomavirus infection and cervical neoplasia: A systematic review and meta-analysis. Am J Epidemiol 2008; 168:123-137..
31. Cuschieri KS, Cubie HA, Whitley MW, et al. Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol 2005; 58:946-950.
32. Iftner T, Villa LL. Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr 2003; 31:80-88.